BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cabezudo D, Baekelandt V, Lobbestael E. Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and Inflammation. Front Neurosci 2020;14:376. [PMID: 32410948 DOI: 10.3389/fnins.2020.00376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Yin Q, Cheng XY, Zhang JR, Jin H, Li K, Mao CJ, Wang F, Bei HZ, Liu CF. G2019S LRRK2 Mutation Enhances MPP+-Induced Inflammation of Human Induced Pluripotent Stem Cells-Differentiated Dopaminergic Neurons. Front Neurosci 2022;16:947927. [PMID: 35873822 DOI: 10.3389/fnins.2022.947927] [Reference Citation Analysis]
2 Tsafaras G, Baekelandt V. The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases. Neurobiol Dis 2022;172:105806. [PMID: 35781002 DOI: 10.1016/j.nbd.2022.105806] [Reference Citation Analysis]
3 Brown RE. Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress? The EuroBiotech Journal 2022;6:61-88. [DOI: 10.2478/ebtj-2022-0008] [Reference Citation Analysis]
4 Ahmadi Rastegar D, Hughes LP, Perera G, Keshiya S, Zhong S, Gao J, Halliday GM, Schüle B, Dzamko N. Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages. NPJ Parkinsons Dis 2022;8:34. [PMID: 35347144 DOI: 10.1038/s41531-022-00297-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rodrigues-costa M, Fernandes MSDS, Jurema-santos GC, Gonçalves LVDP, Andrade-da-costa BLDS. Nutrigenomics in Parkinson’s disease: diversity of modulatory actions of polyphenols on epigenetic effects induced by toxins. Nutritional Neuroscience. [DOI: 10.1080/1028415x.2021.2017662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Iannotta L, Greggio E. LRRK2 signaling in neurodegeneration: two decades of progress. Essays Biochem 2021:EBC20210013. [PMID: 34897411 DOI: 10.1042/EBC20210013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sanchiz-Calvo M, Bentea E, Baekelandt V. Rodent models based on endolysosomal genes involved in Parkinson's disease. Curr Opin Neurobiol 2021;72:55-62. [PMID: 34628360 DOI: 10.1016/j.conb.2021.09.004] [Reference Citation Analysis]
8 Sjögren M, Huttunen HJ, Svenningsson P, Widner H. Genetically Targeted Clinical Trials in Parkinson's Disease: Learning from the Successes Made in Oncology. Genes (Basel) 2021;12:1529. [PMID: 34680924 DOI: 10.3390/genes12101529] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Fenner BM, Fenner ME, Prowse N, Hayley SP. LRRK2 and WAVE2 regulate microglial-transition through distinct morphological phenotypes to induce neurotoxicity in a novel two-hit in vitro model of neurodegeneration. J Cell Physiol 2021. [PMID: 34543438 DOI: 10.1002/jcp.30588] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Renner H, Schöler HR, Bruder JM. Combining Automated Organoid Workflows With Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond. Mov Disord 2021. [PMID: 34498298 DOI: 10.1002/mds.28775] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Macías-García D, Periñán MT, Muñoz-Delgado L, Jimenez-Jaraba MV, Labrador-Espinosa MÁ, Jesús S, Buiza-Rueda D, Méndez-Del Barrio C, Adarmes-Gómez A, Gómez-Garre P, Mir P. Serum lipid profile among sporadic and familial forms of Parkinson's disease. NPJ Parkinsons Dis 2021;7:59. [PMID: 34272400 DOI: 10.1038/s41531-021-00206-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Van Camp N, Lavisse S, Roost P, Gubinelli F, Hillmer A, Boutin H. TSPO imaging in animal models of brain diseases. Eur J Nucl Med Mol Imaging 2021. [PMID: 34245328 DOI: 10.1007/s00259-021-05379-z] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
13 Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, Beers DR, Lai EC, Appel SH. Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease. NPJ Parkinsons Dis 2021;7:41. [PMID: 33986285 DOI: 10.1038/s41531-021-00188-5] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
14 Goveas L, Mutez E, Chartier-Harlin MC, Taymans JM. Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells. Cells 2021;10:981. [PMID: 33922322 DOI: 10.3390/cells10050981] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Petiet A. Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson's Disease: A Review. Front Neurosci 2021;15:583678. [PMID: 33897339 DOI: 10.3389/fnins.2021.583678] [Reference Citation Analysis]
16 Harms AS, Ferreira SA, Romero-Ramos M. Periphery and brain, innate and adaptive immunity in Parkinson's disease. Acta Neuropathol 2021;141:527-45. [PMID: 33555429 DOI: 10.1007/s00401-021-02268-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 39.0] [Reference Citation Analysis]
17 Pischedda F, Piccoli G. LRRK2 at the pre-synaptic site: A 16-years perspective. J Neurochem 2021;157:297-311. [PMID: 33206398 DOI: 10.1111/jnc.15240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang XL, Feng ST, Wang YT, Yuan YH, Li ZP, Chen NH, Wang ZZ, Zhang Y. Mitophagy, a Form of Selective Autophagy, Plays an Essential Role in Mitochondrial Dynamics of Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33528716 DOI: 10.1007/s10571-021-01039-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson's disease: common pathophysiological links. Gut 2021;70:408-17. [PMID: 33067333 DOI: 10.1136/gutjnl-2020-322429] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 18.0] [Reference Citation Analysis]
20 Chittoor-Vinod VG, Nichols RJ, Schüle B. Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism. Int J Mol Sci 2021;22:1045. [PMID: 33494262 DOI: 10.3390/ijms22031045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
21 Tan JSY, Chao YX, Rötzschke O, Tan EK. New Insights into Immune-Mediated Mechanisms in Parkinson's Disease. Int J Mol Sci 2020;21:E9302. [PMID: 33291304 DOI: 10.3390/ijms21239302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 D'Mello SR, Kindy MC. Overdosing on iron: Elevated iron and degenerative brain disorders. Exp Biol Med (Maywood) 2020;245:1444-73. [PMID: 32878460 DOI: 10.1177/1535370220953065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
23 Lopez G, Lazzeri G, Rappa A, Isimbaldi G, Cribiù FM, Guerini-Rocco E, Ferrero S, Vaira V, Di Fonzo A. Comprehensive Genomic Analysis Reveals the Prognostic Role of LRRK2 Copy-Number Variations in Human Malignancies. Genes (Basel) 2020;11:E846. [PMID: 32722212 DOI: 10.3390/genes11080846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]